Li Yu

13.6k total citations
410 papers, 9.1k citations indexed

About

Li Yu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Li Yu has authored 410 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Molecular Biology, 119 papers in Hematology and 83 papers in Oncology. Recurrent topics in Li Yu's work include Acute Myeloid Leukemia Research (94 papers), Epigenetics and DNA Methylation (46 papers) and Histone Deacetylase Inhibitors Research (29 papers). Li Yu is often cited by papers focused on Acute Myeloid Leukemia Research (94 papers), Epigenetics and DNA Methylation (46 papers) and Histone Deacetylase Inhibitors Research (29 papers). Li Yu collaborates with scholars based in China, United States and Germany. Li Yu's co-authors include Shu‐Hsia Chen, Sergei Kusmartsev, Qian Qian, Ping Zhan, Chunhua Xu, Ping Zhan, Xiaoning Gao, Yonghui Li, Lili Wang and Liping Dou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Li Yu

393 papers receiving 9.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Li Yu 4.8k 2.0k 1.8k 1.8k 1.6k 410 9.1k
David Murray 4.0k 0.8× 1.5k 0.8× 971 0.5× 1.6k 0.9× 612 0.4× 286 9.7k
Alice L. Yu 6.1k 1.3× 2.8k 1.4× 1.8k 1.0× 590 0.3× 2.1k 1.3× 297 11.9k
Hiroaki Kataoka 4.0k 0.8× 1.9k 0.9× 1.3k 0.7× 687 0.4× 1.1k 0.7× 295 8.1k
G Steiner 3.9k 0.8× 2.1k 1.1× 855 0.5× 988 0.5× 3.6k 2.2× 286 11.7k
Daniel M. Sullivan 5.6k 1.2× 3.1k 1.6× 702 0.4× 1.2k 0.7× 953 0.6× 235 9.4k
Walter N. Hittelman 7.4k 1.5× 3.8k 1.9× 2.5k 1.4× 1.7k 0.9× 984 0.6× 223 12.2k
Michelle Haber 5.4k 1.1× 3.4k 1.7× 2.0k 1.1× 658 0.4× 657 0.4× 229 9.8k
Éric Boilard 3.5k 0.7× 727 0.4× 1.1k 0.6× 1.6k 0.9× 1.7k 1.0× 125 7.1k
Michael Fiegl 2.3k 0.5× 1.9k 1.0× 1.1k 0.6× 1.3k 0.7× 841 0.5× 165 5.9k
Erik A.C. Wiemer 4.8k 1.0× 2.4k 1.2× 2.1k 1.2× 683 0.4× 510 0.3× 158 8.2k

Countries citing papers authored by Li Yu

Since Specialization
Citations

This map shows the geographic impact of Li Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yu more than expected).

Fields of papers citing papers by Li Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yu. The network helps show where Li Yu may publish in the future.

Co-authorship network of co-authors of Li Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Yu. A scholar is included among the top collaborators of Li Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Yu. Li Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhenghao, Keming Li, Zhe Yu, et al.. (2025). Targeting PRDX1 impairs acute myeloid leukemic blasts and stem cells by disrupting redox homeostasis. Cell Death and Disease. 16(1). 627–627.
2.
Zhou, Wei, Siying Li, Hong Wang, et al.. (2024). A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia. Experimental Hematology and Oncology. 13(1). 9–9. 9 indexed citations
3.
Yan, Jun, Jingbo Chen, Lizhong He, et al.. (2024). Characterisation of the volatile compounds in nine varieties and three breeding selections of celery using GC–IMS and GC–MS. Food Chemistry X. 24. 101936–101936. 4 indexed citations
4.
Zhang, Yin, Yongbo Lu, Xiaoxi Gong, et al.. (2024). Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway. Journal of Ethnopharmacology. 324. 117737–117737. 5 indexed citations
5.
Wang, Lina, Li Yu, Cong Liang, et al.. (2024). The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia. Technology in Cancer Research & Treatment. 23. 2223964968–2223964968. 2 indexed citations
6.
Yu, Li, Doudou Zhang, Miao Liu, et al.. (2023). Exosomal circ_0008285 in follicle fluid regulates the lipid metabolism through the miR-4644/ LDLR axis in polycystic ovary syndrome. Journal of Ovarian Research. 16(1). 113–113. 13 indexed citations
7.
8.
Knopik, Valerie S., Lauren Micalizzi, Kristine Marceau, et al.. (2022). The roles of familial transmission and smoking during pregnancy on executive function skills: A sibling-comparison study. Development and Psychopathology. 34(5). 1803–1815. 3 indexed citations
9.
Wang, Lixin, Lu Xu, Ruiqi Wang, et al.. (2022). Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype. Oncogene. 41(42). 4696–4708. 7 indexed citations
10.
Gao, Xuefeng, et al.. (2021). The Advances and Challenges of NK Cell-Based Cancer Immunotherapy. Current Oncology. 28(2). 1077–1093. 36 indexed citations
11.
Wang, Ruiqi, Chongjian Chen, Yu Jing, et al.. (2020). Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next‐generation sequencing technique. Cancer Medicine. 9(22). 8457–8467. 37 indexed citations
12.
Liu, Zhenbin, Menghu Li, Li Yu, et al.. (2019). Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality. BioMed Research International. 2019. 1–12. 41 indexed citations
13.
Xu, Qingyu, Yan Li, Na Lv, et al.. (2017). Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis. Clinical Cancer Research. 23(15). 4511–4522. 75 indexed citations
14.
Li, Yan, Mingjuan Liu, Bing Zhai, et al.. (2017). Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5‐year retrospective study. Internal Medicine Journal. 48(6). 713–720. 2 indexed citations
15.
Wang, Wei, Chunhua Xu, Yu‐Chao Wang, Li Yu, & Xiuwei Zhang. (2016). Prognostic values of B7-H4 in non-small cell lung cancer. Biomarkers. 1–16. 12 indexed citations
16.
Kupperman, Erik, Edmund C. Lee, Yueying Cao, et al.. (2010). Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer. Cancer Research. 70(5). 1970–1980. 409 indexed citations
17.
Wang, Longxin, Weihong Wen, Jianlin Yuan, et al.. (2009). Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells. Clinical Cancer Research. 16(1). 164–173. 35 indexed citations
18.
Whitman, Susan P., Björn Hackanson, Sandya Liyanarachchi, et al.. (2008). DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood. 112(5). 2013–2016. 56 indexed citations
19.
Tang, Juan, Hongwei Zhou, Jian‐Li Jiang, et al.. (2007). BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.. PubMed. 232(3). 344–52. 35 indexed citations
20.
Dorrance, Anne M., Weifeng Yuan, Brian Becknell, et al.. (2006). Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. Journal of Clinical Investigation. 116(10). 2707–2716. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Murray Breakdown of academic impact, for papers by Alice L. Yu Breakdown of academic impact, for papers by Hiroaki Kataoka Breakdown of academic impact, for papers by G Steiner Breakdown of academic impact, for papers by Daniel M. Sullivan Breakdown of academic impact, for papers by Walter N. Hittelman Breakdown of academic impact, for papers by Michelle Haber Breakdown of academic impact, for papers by Éric Boilard Breakdown of academic impact, for papers by Michael Fiegl Breakdown of academic impact, for papers by Erik A.C. Wiemer
Rankless by CCL
2026